Amedeo Smart

Free Medical Literature Service


 

Amedeo

Anemia

  Free Subscription

Articles published in
Br J Haematol
    August 2022
  1. MORICONI C, Dzieciatkowska M, Roy M, D'Alessandro A, et al
    Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease.
    Br J Haematol. 2022;198:574-586.
    >> Share

  2. ROY NBA, Da Costa L, Russo R, Bianchi P, et al
    The use of next-generation sequencing in the diagnosis of rare inherited anaemias: A Joint BSH/EHA Good Practice Paper.
    Br J Haematol. 2022;198:459-477.
    >> Share

  3. NISHIMURA JI, Usuki K, Ramos J, Ichikawa S, et al
    Crovalimab for treatment of patients with paroxysmal nocturnal haemoglobinuria and complement C5 polymorphism: Subanalysis of the phase 1/2 COMPOSER study.
    Br J Haematol. 2022;198:e46-e50.
    >> Share

  4. GAARTMAN AE, Strijdhorst A, van Es N, Tang MW, et al
    Limited value of the D-dimer based YEARS algorithm to rule out pulmonary embolism in sickle cell disease and sickle cell trait.
    Br J Haematol. 2022;198:e42-e45.
    >> Share

    July 2022
  5. SCOTT C, Bartolovic K, Clark SA, Waithe D, et al
    Functional impairment of erythropoiesis in Congenital Dyserythropoietic Anaemia type I arises at the progenitor level.
    Br J Haematol. 2022;198:e10-e14.
    >> Share

  6. COOPER-SOOD JB, Hagar W, Marsh A, Hoppe C, et al
    Adjuvant low-dose ketamine for paediatric and young adult sickle cell vaso-occlusive episodes in the emergency department.
    Br J Haematol. 2022;198:207-209.
    >> Share

  7. BUESCHE G, Teoman H, Schneider RK, Ribezzo F, et al
    Evolution of severe (transfusion-dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage-associated failure of the eythropoietic niche.
    Br J Haematol. 2022;198:114-130.
    >> Share

  8. CAUGHEY MC, Derebail VK, Carden MA, Novelli EM, et al
    Prevalence and outcomes of dehydration in adults with sickle cell trait: the Atherosclerosis Risk in Communities (ARIC) study.
    Br J Haematol. 2022;198:397-400.
    >> Share

  9. GUO JJ, Cao L, Zhu HY, Miao Y, et al
    T-cell large granular lymphocytic leukaemia with atypical immunophenotypes: A single-centre retrospective analysis of 17 cases.
    Br J Haematol. 2022;198:e18-e22.
    >> Share

  10. KONGKIATKAMON S
    Acute haemolysis following COVID-19 vaccination in a thalassaemic patient with G6PD deficiency.
    Br J Haematol. 2022;198:221.
    >> Share

  11. EARLY ML, Linton E, Bosch A, Campbell T, et al
    The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains.
    Br J Haematol. 2022;198:382-390.
    >> Share

    June 2022
  12. DELAPORTA P, Terpos E, Solomou EE, Gumeni S, et al
    Immune response and adverse events after vaccination against SARS-CoV-2 in adult patients with transfusion-dependent thalassaemia.
    Br J Haematol. 2022;197:576-579.
    >> Share

  13. PICCIN A, O'Connor-Byrne N, Daves M, Lynch K, et al
    Autoimmune disease and sickle cell anaemia: 'Intersecting pathways and differential diagnosis'.
    Br J Haematol. 2022;197:518-528.
    >> Share

  14. HAN J, Molokie RE, Hussain F, Njoku F, et al
    Voxelotor and albuminuria in adults with sickle cell anaemia.
    Br J Haematol. 2022;197:e63-e64.
    >> Share

  15. SHEEHAN VA, van Beers EJ, Connes P, van Wijk R, et al
    Comment on: Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia.
    Br J Haematol. 2022;197:e61-e62.
    >> Share

  16. JOLY P, Boisson C, Renoux C, Caillat N, et al
    Determinants of the point of sickling measured by oxygen gradient ektacytometry in sickle cell anaemia.
    Br J Haematol. 2022;197:e56-e58.
    >> Share

  17. NARDO-MARINO A, Petersen J, Brewin JN, Birgens H, et al
    Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia.
    Br J Haematol. 2022;197:609-617.
    >> Share

  18. MARSHALL WH 5TH, Cleary EM, Della-Moretta S, Li R, et al
    Elevated tricuspid regurgitation velocity is associated with increased adverse haematologic events during pregnancy in women with sickle cell disease.
    Br J Haematol. 2022;197:795-801.
    >> Share

    May 2022
  19. AMID A, Barrowman N, Odame I, Kirby-Allen M, et al
    Optimizing transfusion therapy for survivors of Haemoglobin Bart's hydrops fetalis syndrome: Defining the targets for haemoglobin-H fraction and "functional" haemoglobin level.
    Br J Haematol. 2022;197:373-376.
    >> Share

  20. LONGORIA JN, Heitzer AM, Hankins JS, Trpchevska A, et al
    Neurocognitive risk in sickle cell disease: Utilizing neuropsychology services to manage cognitive symptoms and functional limitations.
    Br J Haematol. 2022;197:260-270.
    >> Share

  21. BAIN BJ, Littlewood T, Rees DC
    What does the term 'sickle cell disease' mean?
    Br J Haematol. 2022;197:381-382.
    >> Share

  22. ALTER BP, Giri N, McReynolds LJ, Altintas B, et al
    Fanconi anaemia: A syndrome with distinct subgroups.
    Br J Haematol. 2022;197:467-474.
    >> Share

  23. VORA SM, Boyd S, Denny N, Jackson E, et al
    Expanded eligibility for emerging therapies in sickle cell disease in the UK - crizanlizumab and voxelotor.
    Br J Haematol. 2022;197:502-504.
    >> Share

    April 2022
  24. TANIGUCHI T, Nakayama S, Tanaka H, Rai S, et al
    Novel prognostic predictor of haemoglobin-platelet index in diffuse large B-cell lymphoma, not otherwise specified: Anaemia and thrombocytopenia are associated with IL-6 production in lymphoma cells.
    Br J Haematol. 2022 Apr 22. doi: 10.1111/bjh.18208.
    >> Share

  25. SUN Y, Habara A, Le CQ, Nguyen N, et al
    Pharmacologic induction of PGC-1alpha stimulates fetal haemoglobin gene expression.
    Br J Haematol. 2022;197:97-109.
    >> Share

  26. RIEU JB, Largeaud L, Da Costa L, Cougoul P, et al
    Unexplained iron overload with haemolytic anaemia should prompt looking for morphological changes in erythroid precursors.
    Br J Haematol. 2022;197:132.
    >> Share

  27. ROSS DM
    Iron chelation for myelofibrosis-related anaemia during treatment with a Janus kinase inhibitor.
    Br J Haematol. 2022;197:135-136.
    >> Share

  28. GARG M, Agarwal S, Altohami M
    A single dose of eculizumab terminated life-threatening haemolysis in idiopathic IgM-mediated warm autoimmune haemolytic anaemia: A case report.
    Br J Haematol. 2022;197:e28-e31.
    >> Share

  29. BATISTA THC, Santana RM, Sobreira MJ, Arcanjo GS, et al
    Up-regulation of miR-130a is related to leg ulcers in sickle cell anaemia.
    Br J Haematol. 2022;197:e16-e18.
    >> Share

  30. TORRES LS, Teles LIM, Shaul ME, Fridlender ZG, et al
    Accelerated low-density neutrophil transition in sickle cell anaemia may contribute to disease pathophysiology.
    Br J Haematol. 2022;197:232-235.
    >> Share

    March 2022
  31. MIODOWNIK H, Curtis SA, Olivia Ogu U, Bradford C, et al
    Frequent health care utilisation and avascular necrosis are associated with cannabis use in adults with sickle cell disease.
    Br J Haematol. 2022;196:e41-e44.
    >> Share

  32. CECCHI N, Giannotta JA, Barcellini W, Fattizzo B, et al
    A case of severe aplastic anaemia after SARS-CoV-2 vaccination.
    Br J Haematol. 2022;196:1334-1336.
    >> Share

  33. CONSTANTINOU V, Papayanni PG, Mallouri D, Batsis I, et al
    Case study of betibeglogene autotemcel gene therapy in an adult Greek patient with transfusion-dependent beta-thalassaemia of a severe genotype.
    Br J Haematol. 2022;196:1401-1404.
    >> Share

  34. CHARNAY T, Cerino M, Gonnet K, Bonello-Palot N, et al
    A novel SUPT5H variant associated with a beta-thalassaemia trait.
    Br J Haematol. 2022;196:e70-e71.
    >> Share

  35. TAMURA S, Hori Y, Hiroi T, Morimoto M, et al
    Pegcetacoplan for refractory paroxysmal nocturnal haemoglobinuria associated with the C5 genetic variant.
    Br J Haematol. 2022;196:e57-e60.
    >> Share

    February 2022
  36. RUND D
    Laboratory diagnosis of iron deficiency: look out for the 'PITTs'.
    Br J Haematol. 2022;196:464-465.
    >> Share

  37. XU LP, Yu Y, Cheng YF, Zhang YY, et al
    Development and validation of a mortality predicting scoring system for severe aplastic anaemia patients receiving haploidentical allogeneic transplantation.
    Br J Haematol. 2022;196:735-742.
    >> Share

  38. FLETCHER A, Forbes A, Svenson N, Wayne Thomas D, et al
    Guideline for the laboratory diagnosis of iron deficiency in adults (excluding pregnancy) and children.
    Br J Haematol. 2022;196:523-529.
    >> Share

  39. POPLAWSKA M, Dutta D, Jayaram M, Salifu M, et al
    Intestinal pathophysiological abnormalities in steady state and after vaso-occlusive crisis in murine sickle cell disease.
    Br J Haematol. 2022;196:777-780.
    >> Share

  40. GERRITSMA J, Bongaerts V, Eckhardt C, Heijboer H, et al
    Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease.
    Br J Haematol. 2022;196:769-776.
    >> Share

  41. BARADE A, Aboobacker F, Korula A, Lakshmi K, et al
    Impact of donor telomere length on survival in patients undergoing matched sibling donor transplantation for aplastic anaemia.
    Br J Haematol. 2022;196:724-734.
    >> Share

  42. MAGGIO A
    Cell erythroid maturation approach: a new paradigm in the road map towards a cure for beta-thalassaemia syndromes.
    Br J Haematol. 2022;196:806-808.
    >> Share

  43. OAKLEY LL, Mitchell S, von Rege I, Hadebe R, et al
    Perinatal outcomes in women with sickle cell disease: a matched cohort study from London, UK.
    Br J Haematol. 2022;196:1069-1075.
    >> Share

  44. VLACHODIMITROPOULOU E, Garbowski M, Anne Solomon S, Abbasi N, et al
    Outcome predictors for maternal red blood cell alloimmunisation with anti-K and anti-D managed with intrauterine blood transfusion.
    Br J Haematol. 2022;196:1096-1104.
    >> Share

  45. JONASSAINT CR, Lukombo I, Feldman R, Driscoll J, et al
    Differences in the prevalence of mental health disorders among Black American adults with sickle cell disease compared to those with non-heritable medical conditions or no medical conditions.
    Br J Haematol. 2022;196:1059-1068.
    >> Share

  46. WHITE J, Callaghan MU, Gao X, Liu K, et al
    Longitudinal assessment of adhesion to vascular cell adhesion molecule-1 at steady state and during vaso-occlusive crises in sickle cell disease.
    Br J Haematol. 2022;196:1052-1058.
    >> Share

  47. TANEJA K, Verma C, Mahajan A
    Can ruxolitinib avert splenectomy in patients with thalassaemia: a short term case series.
    Br J Haematol. 2022;196:1111-1113.
    >> Share

  48. VENUGOPAL J, Wang J, Guo C, Eitzman DT, et al
    Interleukin-1 receptor antagonism leads to improved anaemia in a murine model of sickle cell disease and is associated with reduced ex vivo platelet-mediated erythrocyte sickling.
    Br J Haematol. 2022;196:1040-1051.
    >> Share

    January 2022
  49. NAVILLE AS, Lazaro E, Boutin J, Prot-Leurent C, et al
    Acquired glucose 6-phosphate dehydrogenase (G6PD) deficiency in a patient with Chronic Myelomonocytic Leukemia.
    Br J Haematol. 2022 Jan 6. doi: 10.1111/bjh.18037.
    >> Share

  50. BRODSKY RA, Lee JW, Nishimura JI, Szer J, et al
    Lactate dehydrogenase versus haemoglobin: which one is the better marker in paroxysmal nocturnal haemoglobinuria?
    Br J Haematol. 2022;196:264-265.
    >> Share

  51. RUND D
    A Paradigm shift in genotype-phenotype relationships in beta-thalassaemia.
    Br J Haematol. 2022;196:270-271.
    >> Share

  52. ROY NBA
    Iron overload in inherited anaemias: why one size can't fit all.
    Br J Haematol. 2022;196:266-267.
    >> Share

  53. SMITH WR, McClish DK, Lottenberg R, Sisler IY, et al
    A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence.
    Br J Haematol. 2022;196:193-203.
    >> Share

  54. CHAPIN J, Cohen AR, Neufeld EJ, Vichinsky E, et al
    An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres.
    Br J Haematol. 2022;196:380-389.
    >> Share

  55. MUSALLAM KM, Vitrano A, Meloni A, Addario Pollina S, et al
    Primary HBB gene mutation severity and long-term outcomes in a global cohort of beta-thalassaemia.
    Br J Haematol. 2022;196:414-423.
    >> Share

  56. SHAH FT, Porter JB, Sadasivam N, Kaya B, et al
    Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias.
    Br J Haematol. 2022;196:336-350.
    >> Share

  57. CHEN N, Li Z, Huang Y, Xiao C, et al
    Iron parameters in pregnant women with beta-thalassaemia minor combined with iron deficiency anaemia compared to pregnant women with iron deficiency anaemia alone demonstrate the safety of iron supplementation in beta-thalassaemia minor during pregnan
    Br J Haematol. 2022;196:390-396.
    >> Share

  58. KIENZLE SL, Rodeghier M, Liem RI
    Heart rate variability associated with acute exercise challenge in children with sickle cell anaemia.
    Br J Haematol. 2022;196:397-401.
    >> Share

  59. ADEBAYO OC, Betukumesu DK, Nkoy AB, Adesoji OM, et al
    Clinical and genetic factors are associated with kidney complications in African children with sickle cell anaemia.
    Br J Haematol. 2022;196:204-214.
    >> Share

  60. GRIFFIN R, Panayiotou A, Allen P, Height S, et al
    What is the role of chest X-ray imaging in the acute management of children with sickle cell disease?
    Br J Haematol. 2022;196:402-413.
    >> Share

  61. COLMAN KS, Pavord S, Roy N
    A quality improvement project for the cost-effective management of maternal anaemia.
    Br J Haematol. 2022;196:445-448.
    >> Share

  62. VASSEUR C, Domingues-Hamdi E, Pakdaman S, Galacteros F, et al
    Alpha haemoglobin-stabilising protein concentration in the red blood cells of patients with sickle cell anaemia with and without hydroxycarbamide treatment.
    Br J Haematol. 2022;196:183-192.
    >> Share

  63. RISITANO AM, Peffault de Latour R
    How we('ll) treat paroxysmal nocturnal haemoglobinuria: diving into the future.
    Br J Haematol. 2022;196:288-303.
    >> Share

  64. DEXTER D, McGann PT
    Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease.
    Br J Haematol. 2022;196:63-69.
    >> Share

  65. MANABE M, Hagiwara Y, Asada R, Tanizawa N, et al
    Acquired elliptocytosis in a patient with myelodysplastic syndrome harbouring a novel unbalanced whole-arm translocation, der(14;20)(q10;p10).
    Br J Haematol. 2022;196:7.
    >> Share

  66. BARRITEAU CM, Chiu A, Rodeghier M, Liem RI, et al
    Cerebral and skeletal muscle tissue oxygenation during exercise challenge in children and young adults with sickle cell anaemia.
    Br J Haematol. 2022;196:179-182.
    >> Share

  67. HUGHES AD, Kurre P
    The impact of clonal diversity and mosaicism on haematopoietic function in Fanconi anaemia.
    Br J Haematol. 2022;196:274-287.
    >> Share

  68. GABELLI M, Ademokun C, Cooper N, Amrolia PI, et al
    Pathogenesis, risk factors and therapeutic options for autoimmune haemolytic anaemia in the post-transplant setting.
    Br J Haematol. 2022;196:45-62.
    >> Share

    December 2021
  69. AOUN SA, Motabi I
    Cold agglutinin disease after COVID-19 vaccine.
    Br J Haematol. 2021;195:650.
    >> Share

  70. LIN J, Ye Y, Shang X, Zhang Y, et al
    TEA domain transcription factor 4 modulates repression of fetal haemoglobin by direct binding to the gamma-globin gene promoters.
    Br J Haematol. 2021;195:764-769.
    >> Share

  71. NAKAGAWA N, Ishiyama K, Tanabe M, Yoroidaka T, et al
    The effectiveness of immunosuppressive therapy in patients with aplastic anaemia secondary to chemoradiotherapy for cancers.
    Br J Haematol. 2021;195:770-780.
    >> Share

  72. BADAWY SM, Payne AB, Hulihan MM, Coates TD, et al
    Concordance with comprehensive iron assessment, hepatitis A vaccination, and hepatitis B vaccination recommendations among patients with sickle cell disease and thalassaemia receiving chronic transfusions: an analysis from the Centers for Disease Cont
    Br J Haematol. 2021;195:e160-e164.
    >> Share

  73. WILSON SR, Sears M, Williams E, Drapekin J, et al
    Gaps in the diagnosis and management of iron overload in sickle cell disease: a 'real-world' report from the GRNDaD registry.
    Br J Haematol. 2021;195:e157-e160.
    >> Share

    November 2021
  74. HALL R, Meenan J, Mihalca D, Katumba A, et al
    The real impact of COVID-19 on an East London Sickle cell population: results of a service-wide survey.
    Br J Haematol. 2021;195:532-535.
    >> Share

  75. LILES DK, Shah NR, Scullin B, Gordeuk VR, et al
    Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study.
    Br J Haematol. 2021;195:e150-e153.
    >> Share

  76. EL-AMIN N, Lauzon SD, Nietert PJ, Kanter J, et al
    Which adults with sickle cell disease need an evaluation for pulmonary embolism?
    Br J Haematol. 2021;195:447-455.
    >> Share

  77. WANG W, Freeman M, Hamilton L, Carroll Y, et al
    Developmental screening of three-year-old children with sickle cell disease compared to controls.
    Br J Haematol. 2021;195:621-628.
    >> Share

  78. BOISSON C, Renoux C, Nader E, Gauthier A, et al
    Comparisons of oxygen gradient ektacytometry parameters between sickle cell patients with or without alpha-thalassaemia.
    Br J Haematol. 2021;195:629-633.
    >> Share

  79. LAFAURIE M, Maquet J, Baricault B, Ekstrand C, et al
    Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
    Br J Haematol. 2021;195:456-465.
    >> Share

  80. RANKINE-MULLINGS A, Reid M, Soares D, Taylor-Bryan C, et al
    Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial.
    Br J Haematol. 2021;195:612-620.
    >> Share

  81. BALLAS SK, Kuypers FA, Gordeuk VR, Hankins JS, et al
    Time to rethink haemoglobin threshold guidelines in sickle cell disease.
    Br J Haematol. 2021;195:518-522.
    >> Share

    October 2021
  82. HE Z, Sun X, Wang S, Bai D, et al
    Ggct (gamma-glutamyl cyclotransferase) plays an important role in erythrocyte antioxidant defense and red blood cell survival.
    Br J Haematol. 2021;195:267-275.
    >> Share

  83. KARKOSKA K
    Neuroprotection: further evidence for the early and universal use of hydroxyurea in children with sickle cell disease.
    Br J Haematol. 2021;195:158-159.
    >> Share

  84. CAPPELLI B, Scigliuolo GM, Boukouaci W, Rafii H, et al
    Impact of the human leucocyte antigen (HLA)-B leader peptide dimorphism and HLA-A expression on outcomes of stem cell transplantation for sickle cell disease.
    Br J Haematol. 2021;195:e128-e131.
    >> Share

  85. HEITZER AM, Longoria J, Okhomina V, Wang WC, et al
    Hydroxyurea treatment and neurocognitive functioning in sickle cell disease from school age to young adulthood.
    Br J Haematol. 2021;195:256-266.
    >> Share

  86. DEREBAIL VK, Zhou Q, Ciccone EJ, Cai J, et al
    Longitudinal study of glomerular hyperfiltration and normalization of estimated glomerular filtration in adults with sickle cell disease.
    Br J Haematol. 2021;195:123-132.
    >> Share

    September 2021
  87. MASLAH N, Ravdan O, Drevon L, Verger E, et al
    Revisiting Diagnostic performances of serum erythropoietin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement.
    Br J Haematol. 2021 Sep 25. doi: 10.1111/bjh.17848.
    >> Share

  88. BARCELLINI W, Fattizzo B, Giannotta JA, Quattrocchi L, et al
    COVID-19 in patients with paroxysmal nocturnal haemoglobinuria: an Italian multicentre survey.
    Br J Haematol. 2021;194:854-856.
    >> Share

  89. MUNARETTO V, Voi V, Palazzi G, Notarangelo LD, et al
    Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned.
    Br J Haematol. 2021;194:851-854.
    >> Share

  90. HINES PC, Callaghan MU, Zaidi AU, Gao X, et al
    Flow adhesion of whole blood to P-selectin: a prognostic biomarker for vaso-occlusive crisis in sickle cell disease.
    Br J Haematol. 2021;194:1074-1082.
    >> Share

  91. OTENG-NTIM E, Pavord S, Howard R, Robinson S, et al
    Management of sickle cell disease in pregnancy. A British Society for Haematology Guideline.
    Br J Haematol. 2021;194:980-995.
    >> Share

  92. STRATTON P
    Standardizing care of those at great risk: the importance of sickle cell in pregnancy practice guidelines.
    Br J Haematol. 2021;194:950-953.
    >> Share

  93. GAARTMAN AE, Sayedi AK, Gerritsma JJ, de Back TR, et al
    Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factors.
    Br J Haematol. 2021;194:899-907.
    >> Share

  94. PECKER LH, Sharma D, Nero A, Paidas MJ, et al
    Knowledge gaps in reproductive and sexual health in girls and women with sickle cell disease.
    Br J Haematol. 2021;194:970-979.
    >> Share

  95. RIEGER MJ, Stolz SM, Ludwig S, Benoit TM, et al
    Daratumumab in rituximab-refractory autoimmune haemolytic anaemia.
    Br J Haematol. 2021;194:931-934.
    >> Share

  96. BOUDHABHAY I, Boutin E, Bartolucci P, Bornes MI, et al
    Impact of pre-eclampsia on renal outcome in sickle cell disease patients.
    Br J Haematol. 2021;194:1053-1062.
    >> Share

  97. MALINOWSKI AK, Kuo KHM, Tomlinson GA, Palcu P, et al
    Distinct maternal and fetal pregnancy outcomes in women with sickle cell disease can be predicted using routine clinical and laboratory data.
    Br J Haematol. 2021;194:1063-1073.
    >> Share

  98. SARAF SL
    The vasculopathic cord between pre-eclampsia and kidney function in sickle cell disease.
    Br J Haematol. 2021;194:947-949.
    >> Share

  99. KUMKHAEK C, Uchida N, Tisdale JF, Rodgers GP, et al
    Comparison of CD34(+) cells isolated from frozen cord blood and fresh adult peripheral blood of sickle cell disease patients in gene correction of the sickle mutation at late-stage erythroid differentiation.
    Br J Haematol. 2021;194:e80-e84.
    >> Share

  100. GOTTGENS EL, Ligthart PC, Veldhuisen B, Veldthuis M, et al
    Rh-null phenotype and stomatocytosis.
    Br J Haematol. 2021;194:803.
    >> Share

  101. SCHEINBERG P
    Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries.
    Br J Haematol. 2021;194:954-969.
    >> Share

    August 2021
  102. NJOKU F, Zhang X, Shah BN, Machado RF, et al
    Biomarkers of clinical severity in treated and untreated sickle cell disease: a comparison by genotypes of a single center cohort and African Americans in the NHANES study.
    Br J Haematol. 2021;194:767-778.
    >> Share

  103. ELSHERIF L, Scott LC, Wichlan D, Jones SK, et al
    Hydroxyurea therapy decreases coagulation and endothelial activation in sickle cell disease: a Longitudinal Study.
    Br J Haematol. 2021;194:e71-e73.
    >> Share

  104. QUINN CT, Niss O, Dong M, Pfeiffer A, et al
    Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia.
    Br J Haematol. 2021;194:617-625.
    >> Share

  105. TANGSRICHAROEN T, Natesirinilkul R, Phusua A, Fanhchaksai K, et al
    Severe neonatal haemolytic anaemia caused by compound heterozygous KLF1 mutations: report of four families and literature review.
    Br J Haematol. 2021;194:626-634.
    >> Share

    July 2021
  106. FATTIZZO B, Rizzo L, Giannotta JA, Mazzon F, et al
    Switching to an alternative recombinant erythropoietin agent in patients with myelodysplastic syndromes: a second honeymoon?
    Br J Haematol. 2021 Jul 26. doi: 10.1111/bjh.17722.
    >> Share

  107. KILLICK SB, Ingram W, Culligan D, Enright H, et al
    British Society for Haematology guidelines for the management of adult myelodysplastic syndromes.
    Br J Haematol. 2021;194:267-281.
    >> Share

  108. MITTELMAN M, Oster HS
    Thrombocytopenia in myelodysplastic syndromes: time to lift the embargo on thrombomimetics?
    Br J Haematol. 2021;194:231-233.
    >> Share

  109. RASHKIN SR, Rampersaud E, Kang G, Ataga KI, et al
    Generalization of a genetic risk score for time to first albuminuria in children with sickle cell anaemia: SCCRIP cohort study results.
    Br J Haematol. 2021;194:469-473.
    >> Share

  110. ESTEPP JH, Cong Z, Agodoa I, Kang G, et al
    What drives transcranial Doppler velocity improvement in paediatric sickle cell anaemia: analysis from the Sickle Cell Clinical Research and Intervention Program (SCCRIP) longitudinal cohort study.
    Br J Haematol. 2021;194:463-468.
    >> Share

  111. ALNAFIE AN, Alateeq SA, Al-Muhanna FA, Alsulaiman AM, et al
    Exome sequencing in high and low fetal haemoglobin Arab-Indian haplotype sickle cell disease.
    Br J Haematol. 2021;194:e61-e64.
    >> Share

  112. PERES L, Monedero Alonso D, Nudel M, Figeac M, et al
    Characterisation of Asp669Tyr Piezo1 cation channel activity in red blood cells: an unexpected phenotype.
    Br J Haematol. 2021;194:e51-e55.
    >> Share

  113. VADOLAS J, Ng GZ, Kysenius K, Crouch PJ, et al
    SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of beta-thalassaemia.
    Br J Haematol. 2021;194:200-210.
    >> Share

  114. TAHER AT, Viprakasit V, Cappellini MD, Kraus D, et al
    Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non-transfusion-dependent beta-thalassaemia.
    Br J Haematol. 2021;194:474-477.
    >> Share

  115. WICKRAMASINGHE W, Dissanayake R, Raj R, Gooneratne L, et al
    The first report of allogeneic haematopoietic stem cell transplantations for bone marrow failure performed in Sri Lanka.
    Br J Haematol. 2021;194:e56-e58.
    >> Share

  116. TAMAGNE M, Pakdaman S, Bartolucci P, Habibi A, et al
    Whole-blood CCR7 expression and chemoattraction in red blood cell alloimmunization.
    Br J Haematol. 2021;194:477-481.
    >> Share

  117. RIEU JB, El Kassir A, Largeaud L, Dion J, et al
    Characteristic vacuolisation of granulocytic and erythroid precursors associated with VEXAS syndrome.
    Br J Haematol. 2021;194:8.
    >> Share

  118. WARE RE, Dertinger SD
    Absence of hydroxyurea-induced mutational effects supports higher utilisation for the treatment of sickle cell anaemia.
    Br J Haematol. 2021;194:252-266.
    >> Share

  119. PACE BS, Starlard-Davenport A, Kutlar A
    Sickle cell disease: progress towards combination drug therapy.
    Br J Haematol. 2021;194:240-251.
    >> Share

    June 2021
  120. PATON C, Mathews L, Groarke EM, Rios O, et al
    COVID-19 infection in patients with severe aplastic anaemia.
    Br J Haematol. 2021;193:902-905.
    >> Share

  121. HANDS K, Taylor C, Kotze A, Richards T, et al
    Preoperative patient blood management during the SARS-CoV-2 pandemic.
    Br J Haematol. 2021;193:1087-1092.
    >> Share

  122. STEINBERG MH
    HbA2 induction: the merit of pancellularity in sickle cell disease.
    Br J Haematol. 2021;193:1032-1033.
    >> Share

  123. HILLS RK
    Diagnosing Diamond-Blackfan anaemia: 'Vorsprung durch Technik'.
    Br J Haematol. 2021;193:1030-1031.
    >> Share

  124. BLAISE D, Savani BN
    Alternative donor transplantation for severe aplastic anaemia in 2021: haplo donor, cord blood or both?
    Br J Haematol. 2021;193:863-864.
    >> Share

  125. PORCU S, Simbula M, Marongiu MF, Perra A, et al
    Delta-globin gene expression improves sickle cell disease in a humanised mouse model.
    Br J Haematol. 2021;193:1228-1237.
    >> Share

  126. VAN DOOIJEWEERT B, Broeks MH, van Beers EJ, Verhoeven-Duif NM, et al
    Dried blood spot metabolomics reveals a metabolic fingerprint with diagnostic potential for Diamond Blackfan Anaemia.
    Br J Haematol. 2021;193:1185-1193.
    >> Share

  127. LIANG Y, Zhang X, Liu Y, Wang L, et al
    GATA zinc finger domain-containing protein 2A (GATAD2A) deficiency reactivates fetal haemoglobin in patients with beta-thalassaemia through impaired formation of methyl-binding domain protein 2 (MBD2)-containing nucleosome remodelling and deacetylatio
    Br J Haematol. 2021;193:1220-1227.
    >> Share

  128. CHILDS RW, Tian X, Vo P, Purev E, et al
    Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome.
    Br J Haematol. 2021;193:951-960.
    >> Share

  129. MAITLAND K, Kiguli S, Olupot-Olupot P, Opoka RO, et al
    Transfusion management of severe anaemia in African children: a consensus algorithm.
    Br J Haematol. 2021;193:1247-1259.
    >> Share

  130. LAAS C, Lambert C, Senior McKenzie T, Sheldon E, et al
    Improving the laboratory diagnosis of pyruvate kinase deficiency.
    Br J Haematol. 2021;193:994-1000.
    >> Share

  131. JANG T, Mo G, Stewart C, Egini O, et al
    Antibiotic use in adults during sickle cell vaso-occlusive crisis: Is it time for a controlled trial?
    Br J Haematol. 2021;193:1281-1283.
    >> Share

  132. MARTINO S, Arlet JB, Odievre MH, Jullien V, et al
    Deficient mitophagy pathways in sickle cell disease.
    Br J Haematol. 2021;193:988-993.
    >> Share

  133. XU Y, Alfaro-Magallanes VM, Babitt JL
    Physiological and pathophysiological mechanisms of hepcidin regulation: clinical implications for iron disorders.
    Br J Haematol. 2021;193:882-893.
    >> Share

  134. JUNG M, Mehta PA, Jiang CS, Rosti RO, et al
    Comparison of the clinical phenotype and haematological course of siblings with Fanconi anaemia.
    Br J Haematol. 2021;193:971-975.
    >> Share

    May 2021
  135. UYOGA S, George EC, Bates I, Olupot-Olupot P, et al
    Point-of-care haemoglobin testing in African hospitals: a neglected essential diagnostic test.
    Br J Haematol. 2021 May 15. doi: 10.1111/bjh.17431.
    >> Share

  136. BARCELLINI W, Colombatti R
    The impact of Parvovirus B19 on hereditary haemolytic anaemias.
    Br J Haematol. 2021;193:703-704.
    >> Share

  137. BOOTH GS, Savani BN, Langston AA
    Pure red blood cell aplasia: patient management pitfalls in major ABO-incompatible haematopoietic cell transplantation.
    Br J Haematol. 2021;193:701-702.
    >> Share

  138. ELBADRY MI, Khaled SAA, Ahmed NM, Abudeif A, et al
    Acute human parvovirus B19 infection triggers immune-mediated transient bone marrow failure syndrome, extreme direct hyperbilirubinaemia and acute hepatitis in patients with hereditary haemolytic anaemias: multicentre prospective pathophysiological st
    Br J Haematol. 2021;193:827-840.
    >> Share

  139. LONGVAL T, Galimard JE, Lepretre AC, Suarez F, et al
    Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study.
    Br J Haematol. 2021;193:814-826.
    >> Share

  140. VINCHI F, Sparla R, Passos ST, Sharma R, et al
    Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias.
    Br J Haematol. 2021;193:637-658.
    >> Share

  141. RUND D
    Intravenous iron: do we adequately understand the short- and long-term risks in clinical practice?
    Br J Haematol. 2021;193:466-480.
    >> Share

  142. SARAF SL, Zhang X, Shah BN, Raslan R, et al
    Engulfment and cell motility 1 (ELMO1) and apolipoprotein A1 (APOA1) as candidate genes for sickle cell nephropathy.
    Br J Haematol. 2021;193:628-632.
    >> Share

  143. DENTON CC, Detterich JA, Coates TD, Wood JC, et al
    Kidney iron deposition by R2* is associated with haemolysis and urinary iron.
    Br J Haematol. 2021;193:633-636.
    >> Share

    April 2021
  144. BERNARD F, Uppungunduri CRS, Meyer S, Cummins M, et al
    Excellent overall and chronic graft-versus-host-disease-free event-free survival in Fanconi anaemia patients undergoing matched related- and unrelated-donor bone marrow transplantation using alemtuzumab-Flu-Cy: the UK experience.
    Br J Haematol. 2021 Apr 14. doi: 10.1111/bjh.17418.
    >> Share

  145. CALABRETTA E, Moraleda JM, Iacobelli M, Jara R, et al
    COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies.
    Br J Haematol. 2021;193:43-51.
    >> Share

  146. BENNETT R, Ruskova A
    Atezolizumab-induced pure red cell aplasia.
    Br J Haematol. 2021;193:10.
    >> Share

  147. LADU AI, Aiyenigba AO, Adekile A, Bates I, et al
    The spectrum of splenic complications in patients with sickle cell disease in Africa: a systematic review.
    Br J Haematol. 2021;193:26-42.
    >> Share

  148. SHAFIEE S, Gelebart P, Popa M, Hellesoy M, et al
    Preclinical characterisation and development of a novel myelodysplastic syndrome-derived cell line.
    Br J Haematol. 2021;193:415-419.
    >> Share

  149. CHENG Y, Shang X, Chen D, Pang D, et al
    MicroRNA-2355-5p regulates gamma-globin expression in human erythroid cells by inhibiting KLF6.
    Br J Haematol. 2021;193:401-405.
    >> Share

  150. QUINTINO DE OLIVEIRA B, Catto LFB, Santana BAA, Tellechea MF, et al
    Eltrombopag preferentially expands haematopoietic multipotent progenitors in human aplastic anaemia.
    Br J Haematol. 2021;193:410-414.
    >> Share

    March 2021
  151. SAULSBERRY-ABATE AC, Partanen M, Porter JS, Podila PSB, et al
    Cognitive performance as a predictor of healthcare transition in sickle cell disease.
    Br J Haematol. 2021;192:1082-1091.
    >> Share

  152. AL-SAMKARI H, Addonizio K, Glader B, Morton DH, et al
    The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency.
    Br J Haematol. 2021;192:1092-1096.
    >> Share

  153. EGOT M, Lasne D, Poirault-Chassac S, Mirault T, et al
    Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome.
    Br J Haematol. 2021;192:909-921.
    >> Share

  154. ATAGA KI, Staffa SJ, Brugnara C, Stocker JW, et al
    Haemoglobin response to senicapoc in patients with sickle cell disease: a re-analysis of the Phase III trial.
    Br J Haematol. 2021;192:e129-e132.
    >> Share

  155. OIKONOMOPOULOU C, Paisiou A, Komitopoulou A, Ioannidou ED, et al
    Increased incidence of autoimmune cytopenias after allogeneic haematopoietic stem cell transplantation using a matched unrelated donor in children with beta-thalassaemia.
    Br J Haematol. 2021;192:e127-e129.
    >> Share

  156. SACHDEV V, Tian X, Gu Y, Nichols J, et al
    A phenotypic risk score for predicting mortality in sickle cell disease.
    Br J Haematol. 2021;192:932-941.
    >> Share

  157. RIBEIRO PR, Teixeira RDS, Souza AR, Pereira TCS, et al
    Blood plasma metabolomics of children and adolescents with sickle cell anaemia treated with hydroxycarbamide: a new tool for uncovering biochemical alterations.
    Br J Haematol. 2021;192:922-931.
    >> Share

    February 2021
  158. CAIRO MS, Savani BN
    Haematopoietic progenitor cell transplantation in adults with symptomatic sickle cell disease: the time has arrived.
    Br J Haematol. 2021;192:678-680.
    >> Share

  159. OLSON TS
    Paediatric severe aplastic anaemia treatment: where to start?
    Br J Haematol. 2021;192:417-419.
    >> Share

  160. ALZAHRANI M, Damlaj M, Jeffries N, Alahmari B, et al
    Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres.
    Br J Haematol. 2021;192:761-768.
    >> Share

  161. YUAN S, Jordan LC, Davis LT, Cogswell PM, et al
    A cross-sectional, case-control study of intracranial arterial wall thickness and complete blood count measures in sickle cell disease.
    Br J Haematol. 2021;192:769-777.
    >> Share

  162. GROARKE EM, Patel BA, Gutierrez-Rodrigues F, Rios O, et al
    Eltrombopag added to immunosuppression for children with treatment-naive severe aplastic anaemia.
    Br J Haematol. 2021;192:605-614.
    >> Share

  163. HOTINSKI AK, Best OG, Thurgood LA, Lower KM, et al
    A biclonal case of chronic lymphocytic leukaemia with discordant mutational status of the immunoglobulin heavy chain variable region and bimodal CD49d expression.
    Br J Haematol. 2021;192:e77-e81.
    >> Share

  164. DEMBELE AK, Lapoumeroulie C, Diaw M, Tessougue O, et al
    Cell-derived microparticles and sickle cell disease chronic vasculopathy in sub-Saharan Africa: A multinational study.
    Br J Haematol. 2021;192:634-642.
    >> Share

  165. VITRANO A, Meloni A, Addario Pollina W, Karimi M, et al
    A complication risk score to evaluate clinical severity of thalassaemia syndromes.
    Br J Haematol. 2021;192:626-633.
    >> Share

  166. CASTLEMAN JS, Moise KJ Jr, Kilby MD
    Medical therapy to attenuate fetal anaemia in severe maternal red cell alloimmunisation.
    Br J Haematol. 2021;192:425-432.
    >> Share

    January 2021
  167. KULASEKARARAJ AG, Marsh JCW
    Romiplostim in aplastic anaemia - another tool in the armamentarium.
    Br J Haematol. 2021;192:15-16.
    >> Share

  168. MINGOIA M, Caria CA, Ye L, Asunis I, et al
    Induction of therapeutic levels of HbF in genome-edited primary beta(0) 39-thalassaemia haematopoietic stem and progenitor cells.
    Br J Haematol. 2021;192:395-404.
    >> Share


  169. Developing the evidence base for the management of autoimmune haemolytic anaemia (AIHA): the UK experience.
    Br J Haematol. 2021;192:e54-e57.
    >> Share

  170. SHARMA POUDYAL B, Gyawali B, Rondelli D
    The need for locally generated data in haematology: a real-world experience of aplastic anaemia in Nepal.
    Br J Haematol. 2021;192:e63-e65.
    >> Share

  171. GREGOIRE-PELCHAT P, Pastore Y, Robitaille N, LeMay S, et al
    Comparison of two vitamin D supplementation strategies in children with sickle cell disease: a randomized controlled trial.
    Br J Haematol. 2021;192:385-394.
    >> Share

  172. PATEL A, Gan K, Li AA, Weiss J, et al
    Machine-learning algorithms for predicting hospital re-admissions in sickle cell disease.
    Br J Haematol. 2021;192:158-170.
    >> Share

  173. JANG JH, Tomiyama Y, Miyazaki K, Nagafuji K, et al
    Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.
    Br J Haematol. 2021;192:190-199.
    >> Share

  174. CHAN LKL, Mak VWM, Chan SCH, Yu ELM, et al
    Liver complications of haemoglobin H disease in adults.
    Br J Haematol. 2021;192:171-178.
    >> Share

  175. MTENGA J, Orf K, Zheng J, Chamba C, et al
    Haematopoietic stem cell transplantation in Tanzania.
    Br J Haematol. 2021;192:17-21.
    >> Share

  176. SPEICH C, Wegmuller R, Brittenham GM, Zeder C, et al
    Measurement of long-term iron absorption and loss during iron supplementation using a stable isotope of iron ((57) Fe).
    Br J Haematol. 2021;192:179-189.
    >> Share

  177. MANARA R, Dalla Torre A, Lucchetta M, Ermani M, et al
    Visual cortex changes in children with sickle cell disease and normal visual acuity: a multimodal magnetic resonance imaging study.
    Br J Haematol. 2021;192:151-157.
    >> Share

    December 2020
  178. RUND D
    The evolution of clinical research in thalassaemia: where has all the funding gone?
    Br J Haematol. 2020;191:666-667.
    >> Share

  179. JOBANPUTRA M, Paramore C, Laird SG, McGahan M, et al
    Co-morbidities and mortality associated with transfusion-dependent beta-thalassaemia in patients in England: a 10-year retrospective cohort analysis.
    Br J Haematol. 2020;191:897-905.
    >> Share

  180. URIO F, Nkya S, Rooks H, Mgaya JA, et al
    F cell numbers are associated with an X-linked genetic polymorphism and correlate with haematological parameters in patients with sickle cell disease.
    Br J Haematol. 2020;191:888-896.
    >> Share

  181. FORTE S, Eng B, Verhovsek M, Soulieres D, et al
    Microcytosis in patients with haemoglobin C trait: is alpha-thalassaemia trait to blame?
    Br J Haematol. 2020;191:e129-e131.
    >> Share

  182. TANG D, Liu S, Sun H, Qin X, et al
    All-trans-retinoic acid shifts Th1 towards Th2 cell differentiation by targeting NFAT1 signalling to ameliorate immune-mediated aplastic anaemia.
    Br J Haematol. 2020;191:906-919.
    >> Share

  183. PECKER LH, Hussain S, Christianson MS, Lanzkron S, et al
    Hydroxycarbamide exposure and ovarian reserve in women with sickle cell disease in the Multicenter Study of Hydroxycarbamide.
    Br J Haematol. 2020;191:880-887.
    >> Share

  184. VALI S, Mukhtar S, Nandi A, Wilson K, et al
    Cumulative outcome of pre-implantation genetic diagnosis for sickle cell disease: a 5-year review.
    Br J Haematol. 2020;191:875-879.
    >> Share

    November 2020
  185. VERLHAC S, Gabor F, Paillard C, Chateil JF, et al
    Improved stenosis outcome in stroke-free sickle cell anemia children after transplantation compared to chronic transfusion.
    Br J Haematol. 2020 Nov 20. doi: 10.1111/bjh.17178.
    >> Share

  186. WEI Z, Yang G, Huang Y, Peng P, et al
    A 15-years follow-up of deferasirox in beta-thalassaemia major patients with iron overload.
    Br J Haematol. 2020;191:e81-e83.
    >> Share

  187. PEZINA-CANTU C, Gomez-De Leon A, Jaime-Perez JC, Colunga-Pedraza P, et al
    Pernicious anaemia can be treated effectively with a single high dose of cobalamin.
    Br J Haematol. 2020;191:e97-e100.
    >> Share

  188. SIRIWORADETKUN S, Thubthed R, Thiengtavor C, Paiboonsukwong K, et al
    Elevated levels of circulating monocytic myeloid derived suppressor cells in splenectomised beta-thalassaemia/HbE patients.
    Br J Haematol. 2020;191:e72-e76.
    >> Share

  189. HAN J, Holden CC, Ahluwalia AY, Molokie RE, et al
    Chronic opioid use can be reduced or discontinued after haematopoietic stem cell transplantation for sickle cell disease.
    Br J Haematol. 2020;191:e70-e72.
    >> Share

  190. PEFFAULT DE LATOUR R, Brodsky RA, Ortiz S, Risitano AM, et al
    Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies.
    Br J Haematol. 2020;191:476-485.
    >> Share

  191. TOLE S, Dhir P, Pugi J, Drury LJ, et al
    Genotype-phenotype correlation in children with hereditary spherocytosis.
    Br J Haematol. 2020;191:486-496.
    >> Share

    October 2020
  192. HERISHANU Y, Levi S, Kamdjou T, Bornstein Y, et al
    Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Br J Haematol. 2020 Oct 23. doi: 10.1111/bjh.17105.
    >> Share

  193. SHEHA D, El-Shayeb M, Eid Y, Amin M, et al
    Unfolding of sickle cell trait by coronavirus disease 2019 (COVID-19) infection.
    Br J Haematol. 2020;191:e38-e40.
    >> Share

  194. PIKE A, Muus P, Munir T, Mitchell L, et al
    COVID-19 infection in patients on anti-complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience.
    Br J Haematol. 2020;191:e1-e4.
    >> Share

  195. ROIZENBLATT S, Cabanas-Pedro AC, Figueiredo MS
    Rheumatoid arthritis and sickle cell disease: A potential association.
    Br J Haematol. 2020;191:e25-e28.
    >> Share

  196. BARGEHR C, Crazzolara R
    Cabot rings and other peripheral blood features of Imerslund-Grasbeck syndrome.
    Br J Haematol. 2020;191:11.
    >> Share

  197. TEOFILI L, Papacci P, Orlando N, Bianchi M, et al
    Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study.
    Br J Haematol. 2020;191:263-268.
    >> Share

  198. RICCHI P, Meloni A, Pistoia L, Spasiano A, et al
    Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study.
    Br J Haematol. 2020;191:107-114.
    >> Share

    September 2020
  199. NESR G, Koshy R, Foldes D, Kagdi H, et al
    Autoimmune haemolytic anaemia and a marked rise in the lymphocyte count associated with COVID-19 in a patient with treatment-naive chronic lymphocytic leukaemia: a case report.
    Br J Haematol. 2020;190:e326-e328.
    >> Share

  200. OLATUNYA OS
    Poverty and severity of childhood sickle cell disease.
    Br J Haematol. 2020;190:819-821.
    >> Share

  201. WOUTERS HJCM, Stam SP, van der Klauw MM, Bakker SJL, et al
    The association between haemoglobin concentrations and muscle mass determined from urinary creatinine excretion rate: a population-based cohort study.
    Br J Haematol. 2020;190:e349-e352.
    >> Share

  202. GERARD D, Bourin S, Phulpin A, Picard V, et al
    Previously misdiagnosed red cell membrane disorder and familial consequences.
    Br J Haematol. 2020;190:810.
    >> Share

  203. LIAPIS K, Vrachiolias G, Spanoudakis E, Kotsianidis I, et al
    Vacuolation of early erythroblasts with ring sideroblasts: a clue to the diagnosis of linezolid toxicity.
    Br J Haematol. 2020;190:809.
    >> Share

  204. MCGINNIS E, Smith TW
    Clostridium perfringens sepsis with spherocytosis and green neutrophil inclusions.
    Br J Haematol. 2020;190:641.
    >> Share

  205. DE SANTIS GC, Costa TCM, Santos FLS, da Silva-Pinto AC, et al
    Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation: a single-institution experience.
    Br J Haematol. 2020;190:e295-e297.
    >> Share

  206. BELLO-MANGA H, Galadanci AA, Abdullahi S, Ali S, et al
    Low educational level of head of household, as a proxy for poverty, is associated with severe anaemia among children with sickle cell disease living in a low-resource setting: evidence from the SPRING trial.
    Br J Haematol. 2020;190:939-944.
    >> Share

    August 2020
  207. KULASEKARARAJ AG, Lazana I, Large J, Posadas K, et al
    Terminal complement inhibition dampens the inflammation during COVID-19.
    Br J Haematol. 2020;190:e141-e143.
    >> Share

  208. KARIMI M, Haghpanah S, Azarkeivan A, Zahedi Z, et al
    Prevalence and mortality in beta-thalassaemias due to outbreak of novel coronavirus disease (COVID-19): the nationwide Iranian experience.
    Br J Haematol. 2020;190:e137-e140.
    >> Share

  209. APPIAH-KUBI A, Acharya S, Fein Levy C, Vlachos A, et al
    Varying presentations and favourable outcomes of COVID-19 infection in children and young adults with sickle cell disease: an additional case series with comparisons to published cases.
    Br J Haematol. 2020;190:e221-e224.
    >> Share

  210. KULASEKARARAJ AG
    Regulatory cells in immune-mediated aplastic anaemia - not Tregs but Bregs.
    Br J Haematol. 2020;190:486-487.
    >> Share

  211. GIBSON JS
    A novel mechanism for pathogenesis of sickle cell disease with therapeutic implications: Band 3 tyrosine phosphorylation.
    Br J Haematol. 2020;190:488-489.
    >> Share

  212. COLOMBATTI R, Andemariam B
    Microvasculopathy and biomarkers in sickle cell disease: the promise of non-invasive real-time in vivo tools.
    Br J Haematol. 2020;190:309-310.
    >> Share

  213. MALINOWSKI AK
    Thrombotic microangiopathy in pregnancy: when you hear hoofbeats, consider the zebras?
    Br J Haematol. 2020;190:306-308.
    >> Share

  214. MOURA PL, Dobbe JGG, Streekstra GJ, Rab MAE, et al
    Rapid diagnosis of hereditary haemolytic anaemias using automated rheoscopy and supervised machine learning.
    Br J Haematol. 2020;190:e250-e255.
    >> Share

  215. ANDREWS C, Maze D, Murphy T, Sibai H, et al
    Combination treatment with CPX-351 and midostaurin in patients with secondary acute myeloid leukaemia that are FLT3 mutated: three cases and review of literature.
    Br J Haematol. 2020;190:467-470.
    >> Share

  216. FILIPPIDOU M, Avgerinou G, Tsipou H, Tourkantoni N, et al
    Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia.
    Br J Haematol. 2020;190:e157-e159.
    >> Share

  217. FUNG EB, Ahmad T, Killilea DW, Hussain R, et al
    Zinc supplementation improves markers of glucose homeostasis in thalassaemia.
    Br J Haematol. 2020;190:e162-e166.
    >> Share

  218. LUEWAN S, Charoenkwan P, Sirichotiyakul S, Tongsong T, et al
    Fetal haemoglobin H-Constant Spring disease: a role for intrauterine management.
    Br J Haematol. 2020;190:e233-e236.
    >> Share

  219. NOOMUNA P, Risinger M, Zhou S, Seu K, et al
    Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease.
    Br J Haematol. 2020;190:599-609.
    >> Share

  220. TIMMERMANS SAMEG, Werion A, Spaanderman MEA, Reutelingsperger CP, et al
    The natural course of pregnancies in women with primary atypical haemolytic uraemic syndrome and asymptomatic relatives.
    Br J Haematol. 2020;190:442-449.
    >> Share

  221. ZAIMOKU Y, Patel BA, Kajigaya S, Feng X, et al
    Deficit of circulating CD19(+) CD24(hi) CD38(hi) regulatory B cells in severe aplastic anaemia.
    Br J Haematol. 2020;190:610-617.
    >> Share

  222. SAMARRON SL, Miller JW, Cheung AT, Chen PC, et al
    Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients.
    Br J Haematol. 2020;190:450-457.
    >> Share

  223. WILSON S, Ellsworth P, Key NS
    Pregnancy in sickle cell trait: what we do and don't know.
    Br J Haematol. 2020;190:328-335.
    >> Share

    July 2020
  224. HEILBRONNER C, Berteloot L, Tremolieres P, Dupic L, et al
    Patients with sickle cell disease and suspected COVID-19 in a paediatric intensive care unit.
    Br J Haematol. 2020;190:e21-e24.
    >> Share

  225. SAHU KK, Siddiqui AD, Cerny J
    Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience.
    Br J Haematol. 2020;190:e86-e89.
    >> Share

  226. LI M, Nguyen CB, Yeung Z, Sanchez K, et al
    Evans syndrome in a patient with COVID-19.
    Br J Haematol. 2020;190:e59-e61.
    >> Share

  227. MCCLOSKEY KA, Meenan J, Hall R, Tsitsikas DA, et al
    COVID-19 infection and sickle cell disease: a UK centre experience.
    Br J Haematol. 2020;190:e57-e58.
    >> Share

  228. CHAKRAVORTY S, Rees D
    Commentary on sickle cell non-invasive prenatal testing article.
    Br J Haematol. 2020;190:20-21.
    >> Share

  229. JEREBTSOVA M, Taye A, Smith N, Afangbedji N, et al
    Association between plasma and urinary orosomucoid and chronic kidney disease in adults with sickle cell disease.
    Br J Haematol. 2020;190:e45-e48.
    >> Share

  230. PEDROSA AM, Lemes RPG
    Gene expression of HIF-1alpha and VEGF in response to hypoxia in sickle cell anaemia: Influence of hydroxycarbamide.
    Br J Haematol. 2020;190:e39-e42.
    >> Share

  231. NARDO-MARINO A, Brousse V, Rees D
    Emerging therapies in sickle cell disease.
    Br J Haematol. 2020;190:149-172.
    >> Share

  232. KATTAMIS A
    Diamond-Blackfan anaemia: understanding an old disease.
    Br J Haematol. 2020;190:14-15.
    >> Share

  233. VAN CAMPEN J, Silcock L, Yau S, Daniel Y, et al
    A novel non-invasive prenatal sickle cell disease test for all at-risk pregnancies.
    Br J Haematol. 2020;190:119-124.
    >> Share

  234. QUARELLO P, Garelli E, Carando A, Cillario R, et al
    A 20-year long term experience of the Italian Diamond-Blackfan Anaemia Registry: RPS and RPL genes, different faces of the same disease?
    Br J Haematol. 2020;190:93-104.
    >> Share

    June 2020
  235. HUSSAIN FA, Njoku FU, Saraf SL, Molokie RE, et al
    COVID-19 infection in patients with sickle cell disease.
    Br J Haematol. 2020;189:851-852.
    >> Share

  236. LUZZATTO L
    PNH phenotypes and their genesis.
    Br J Haematol. 2020;189:802-805.
    >> Share

  237. HYACINTH HI, Idris IM
    Cognitive deficit in sickle cell disease: Is hydroxyurea part of the story?
    Br J Haematol. 2020;189:1014-1015.
    >> Share

  238. GIRELLI D, Busti F
    ERFE regulation in sickle cell disease: complex but promising.
    Br J Haematol. 2020;189:1012-1013.
    >> Share

  239. KHAMPHIKHAM P, Nualkaew T, Pongpaksupasin P, Kaewsakulthong W, et al
    High-level induction of fetal haemoglobin by pomalidomide in beta-thalassaemia/HbE erythroid progenitor cells.
    Br J Haematol. 2020;189:e240-e245.
    >> Share

  240. BREWIN JN, Crowley MP, Kesse-Adu R, Stuart-Smith S, et al
    Catheter associated thromboses in patients with sickle cell anaemia and dual lumen Vortex apheresis ports are common and can be clinically asymptomatic.
    Br J Haematol. 2020;189:e198-e200.
    >> Share

  241. PARTANEN M, Kang G, Wang WC, Krull K, et al
    Association between hydroxycarbamide exposure and neurocognitive function in adolescents with sickle cell disease.
    Br J Haematol. 2020;189:1192-1203.
    >> Share

  242. RICHARDS SJ, Dickinson AJ, Cullen MJ, Griffin M, et al
    Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI-deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry.
    Br J Haematol. 2020;189:954-966.
    >> Share

  243. PRATS-MARTIN C, Mezquita L, Garcia-Canale S, Jimenez-Jambrina M, et al
    Numerous abnormal mitoses in parvovirus B19-infected proerythroblasts.
    Br J Haematol. 2020;189:800.
    >> Share

  244. MANGAONKAR AA, Thawer F, Son J, Ajebo G, et al
    Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease.
    Br J Haematol. 2020;189:1204-1209.
    >> Share

  245. AL-ALI HK, Griesshammer M, Foltz L, Palumbo GA, et al
    Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts.
    Br J Haematol. 2020;189:888-903.
    >> Share

  246. PATEL BJ, Barot SV, Kuzmanovic T, Kerr C, et al
    Distinctive and common features of moderate aplastic anaemia.
    Br J Haematol. 2020;189:967-975.
    >> Share

    May 2020
  247. ZAGORSKI E, Pawar T, Rahimian S, Forman D, et al
    Cold Agglutinin Autoimmune Hemolytic Anemia Associated with Novel Coronavirus (COVID-19).
    Br J Haematol. 2020 May 27. doi: 10.1111/bjh.16892.
    >> Share

  248. ANGILERI F, Legare S, Marino Gammazza A, Conway de Macario E, et al
    Is molecular mimicry the culprit in the autoimmune hemolytic anemia affecting COVID-19 patients?
    Br J Haematol. 2020 May 26. doi: 10.1111/bjh.16883.
    >> Share

  249. LAZARIAN G, Quinquenel A, Bellal M, Siavellis J, et al
    Autoimmune hemolytic anemia associated with Covid-19 infection.
    Br J Haematol. 2020 May 6. doi: 10.1111/bjh.16794.
    >> Share

  250. LOPEZ C, Kim J, Pandey A, Huang T, et al
    Simultaneous Onset of COVID-19 and Autoimmune Hemolytic Anemia.
    Br J Haematol. 2020 May 5. doi: 10.1111/bjh.16786.
    >> Share

  251. ROY NBA, Telfer P, Eleftheriou P, de la Fuente J, et al
    Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic.
    Br J Haematol. 2020;189:635-639.
    >> Share

  252. ANTELO G, Mangaonkar AA, Coltro G, Buradkar A, et al
    Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T).
    Br J Haematol. 2020;189:e104-e108.
    >> Share

  253. SHAH BN, Hassan TO, Zhang X, McClain DA, et al
    Increased iron stores influence glucose metabolism in sickle cell anaemia.
    Br J Haematol. 2020;189:e184-e187.
    >> Share

  254. SKINNER S, Ling Liu K, Lo M, Josset-Lamaugarny A, et al
    Alterations in vascular reactivity in a transgenic mouse model of sickle cell trait.
    Br J Haematol. 2020;189:e154-e157.
    >> Share

  255. GOUVEIA C, Duarte M, Norte S, Alves P, et al
    Osteoarticular infections in paediatric sickle cell disease: in the era of multidrugresistant bacteria.
    Br J Haematol. 2020;189:e147-e150.
    >> Share

  256. PHILIP KEJ, Sadaka AS, Polkey MI, Hopkinson NS, et al
    The prevalence and associated mortality of non-anaemic iron deficiency in older adults: a 14 years observational cohort study.
    Br J Haematol. 2020;189:566-572.
    >> Share

  257. LEONARD A, Tisdale J, Abraham A
    Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?
    Br J Haematol. 2020;189:408-423.
    >> Share

  258. MCCORMICK M, Richardson T, Warady BA, Novelli EM, et al
    Acute kidney injury in paediatric patients with sickle cell disease is associated with increased morbidity and resource utilization.
    Br J Haematol. 2020;189:559-565.
    >> Share

    April 2020
  259. ALI JS, Andrasik F, Berlin KS, Porter J, et al
    Attention difficulties are associated with lower engagement in adult care amongst youth with sickle cell disease.
    Br J Haematol. 2020;189:e27-e30.
    >> Share

  260. FAYAND A, Dzierzynski N, Georgin-Lavialle S, Bachmeyer C, et al
    The association of psychiatric comorbidities with emergency visits and hospitalisations in adult sickle-cell patients: a cohort study.
    Br J Haematol. 2020;189:e21-e23.
    >> Share

  261. ROPER D, Layton M, Rees D, Lambert C, et al
    Laboratory diagnosis of G6PD deficiency. A British Society for Haematology Guideline.
    Br J Haematol. 2020;189:24-38.
    >> Share

  262. THIENGTAVOR C, Siriworadetkun S, Paiboonsukwong K, Fucharoen S, et al
    Increased ferritin levels in non-transfusion-dependent beta degrees -thalassaemia/HbE are associated with reduced CXCR2 expression and neutrophil migration.
    Br J Haematol. 2020;189:187-198.
    >> Share

  263. FUJISAWA M, Yasumoto A, Kato H, Sugawara Y, et al
    The role of anti-complement factor H antibodies in the development of atypical haemolytic uremic syndrome: a possible contribution to abnormality of platelet function.
    Br J Haematol. 2020;189:182-186.
    >> Share

  264. NICKEL RS, Horan JT, Abraham A, Qayed M, et al
    Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease.
    Br J Haematol. 2020;189:162-170.
    >> Share

  265. QUARTA A, Sgherza N, Pasanisi A, Solfrizzi MP, et al
    Switching from dispersible to film coated tablet formulation of deferasirox improves hemoglobin levels and transfusional interval in patients with transfusion-dependent-thalassemia.
    Br J Haematol. 2020;189:e60-e63.
    >> Share

    March 2020
  266. AUERBACH M, Georgieff MK
    Guidelines for iron deficiency in pregnancy: hope abounds: Commentary to accompany: UK guidelines on the management of iron deficiency in pregnancy.
    Br J Haematol. 2020;188:814-816.
    >> Share

  267. AGGARWAL A, Jamwal M, Sharma P, Sachdeva MUS, et al
    Deciphering molecular heterogeneity of Indian families with hereditary spherocytosis using targeted next-generation sequencing: First South Asian study.
    Br J Haematol. 2020;188:784-795.
    >> Share

  268. HANSEN S, Wood DK, Higgins JM
    5-(Hydroxymethyl)furfural restores low-oxygen rheology of sickle trait blood in vitro.
    Br J Haematol. 2020;188:985-993.
    >> Share

  269. CORNELISSE AC, Bergkamp FJM, Griffioen-Keijzer A
    Haemolytic anaemia: an unrecognised side effect of hydroxyurea?
    Br J Haematol. 2020;188:e80-e81.
    >> Share

  270. STALLINGS AM, Majhail NS, Nowacki AS, Onimoe GI, et al
    Paediatric haematologists' attitudes regarding haematopoietic cell transplantation as treatment for sickle cell disease.
    Br J Haematol. 2020;188:976-984.
    >> Share

  271. PAVORD S, Daru J, Prasannan N, Robinson S, et al
    UK guidelines on the management of iron deficiency in pregnancy.
    Br J Haematol. 2020;188:819-830.
    >> Share

    February 2020
  272. NZE C, Fortin B, Freedman R, Mandell E, et al
    Sudden death in sickle cell disease: current experience.
    Br J Haematol. 2020;188:e43-e45.
    >> Share

  273. SANCHEZ-PETITTO G, Drachenberg CB, Mannuel HD, Law JY, et al
    An unusual presentation of paroxysmal nocturnal haemoglobinuria.
    Br J Haematol. 2020;188:347.
    >> Share

  274. SHAH S, Sheth R, Shah K, Patel K, et al
    Safety and effectiveness of thalidomide and hydroxyurea combination in beta-thalassaemia intermedia and major: a retrospective pilot study.
    Br J Haematol. 2020;188:e18-e21.
    >> Share

  275. PEREIRA-MARTINS DA, Coelho-Silva JL, Domingos IF, Weinhauser I, et al
    Association between ANXA2*5681 polymorphism (rs7170178) and osteonecrosis in haemoglobin SS-genotyped patients.
    Br J Haematol. 2020;188:e8-e11.
    >> Share

  276. DUTTA D, Aujla A, Knoll BM, Lim SH, et al
    Intestinal pathophysiological and microbial changes in sickle cell disease: Potential targets for therapeutic intervention.
    Br J Haematol. 2020;188:488-493.
    >> Share

  277. SAITO-BENZ M, Flanagan P, Berry MJ
    Management of anaemia in pre-term infants.
    Br J Haematol. 2020;188:354-366.
    >> Share

    January 2020
  278. SCHOLS S, Nunn MA, Mackie I, Weston-Davies W, et al
    Successful treatment of a PNH patient non-responsive to eculizumab with the novel complement C5 inhibitor coversin (nomacopan).
    Br J Haematol. 2020;188:334-337.
    >> Share

  279. WANG Y, McReynolds LJ, Dagnall C, Katki HA, et al
    Pre-transplant short telomeres are associated with high mortality risk after unrelated donor haematopoietic cell transplant for severe aplastic anaemia.
    Br J Haematol. 2020;188:309-316.
    >> Share

    April 2019
  280. RUND D
    Bittersweet news for the adult sickle cell patient.
    Br J Haematol. 2019;185:9-10.
    >> Share

  281. ZHOU J, Han J, Nutescu EA, Galanter WL, et al
    Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis.
    Br J Haematol. 2019;185:116-127.
    >> Share

  282. NASHASHIBI J, Avraham GR, Schwartz N, Awni Y, et al
    Intravenous iron treatment reduces coagulability in patients with iron deficiency anaemia: a longitudinal study.
    Br J Haematol. 2019;185:93-101.
    >> Share

  283. BELISARIO AR, Vieira ELM, de Almeida JA, Mendes FG, et al
    Low urinary levels of angiotensin-converting enzyme 2 may contribute to albuminuria in children with sickle cell anaemia.
    Br J Haematol. 2019;185:190-193.
    >> Share

  284. MORISSENS M, Castro Rodriguez J, Azerad MA, Besse-Hammer T, et al
    Added value of speckle tracking in the evaluation of cardiac function in patients with sickle cell disease.
    Br J Haematol. 2019;185:151-153.
    >> Share

  285. BRUNSON A, Keegan THM, Mahajan A, Paulukonis S, et al
    Cancer specific survival in patients with sickle cell disease.
    Br J Haematol. 2019;185:128-132.
    >> Share

  286. DAY ME, Rodeghier M, Driggers J, Bean CJ, et al
    A significant proportion of children of African descent with HbSbeta(0) thalassaemia are inaccurately diagnosed based on phenotypic analyses alone.
    Br J Haematol. 2019;185:153-156.
    >> Share

    March 2019
  287. GRACE RF, Mark Layton D, Barcellini W
    How we manage patients with pyruvate kinase deficiency.
    Br J Haematol. 2019;184:721-734.
    >> Share

  288. WHITE J, Lindgren M, Liu K, Gao X, et al
    Sevuparin blocks sickle blood cell adhesion and sickle-leucocyte rolling on immobilized L-selectin in a dose dependent manner.
    Br J Haematol. 2019;184:873-876.
    >> Share

  289. PELLEGRIN S, Haydn-Smith KL, Hampton-O'Neil LA, Hawley BR, et al
    Transduction with BBF2H7/CREB3L2 upregulates SEC23A protein in erythroblasts and partially corrects the hypo-glycosylation phenotype associated with CDAII.
    Br J Haematol. 2019;184:876-881.
    >> Share

  290. ALTER BP, Giri N
    Serum alpha fetoprotein levels in Fanconi anaemia.
    Br J Haematol. 2019;184:1074-1076.
    >> Share

  291. BERGER G, van den Berg E, Smetsers S, Leegte BK, et al
    Fanconi anaemia presenting as acute myeloid leukaemia and myelodysplastic syndrome in adulthood: a family report on co-occurring FANCC and CHEK2 mutations.
    Br J Haematol. 2019;184:1071-1073.
    >> Share

  292. JIANG H, Zhang H, Wang Y, Qi W, et al
    Sirolimus for the treatment of multi-resistant pure red cell aplasia.
    Br J Haematol. 2019;184:1055-1058.
    >> Share

  293. SALEM B, Mitchell R, DeFor TE, Tryon R, et al
    Elevations in serum alpha fetoprotein levels in patients with Fanconi anaemia.
    Br J Haematol. 2019;184:1032-1035.
    >> Share

  294. KANTER J, Heath LE, Knorr J, Agbenyega ET, et al
    Novel findings from the multinational DOVE study on geographic and age-related differences in pain perception and analgesic usage in children with sickle cell anaemia.
    Br J Haematol. 2019;184:1058-1061.
    >> Share

    February 2019
  295. MCGOWAN KE, Malinowski AK, Schuh AC, Whittle W, et al
    Aplastic anaemia in pregnancy - a single centre, North American series.
    Br J Haematol. 2019;184:436-439.
    >> Share

  296. LUZZATTO L, Notaro R
    The "escape" model: a versatile mechanism for clonal expansion.
    Br J Haematol. 2019;184:465-466.
    >> Share

  297. RAVERA S, Degan P, Sabatini F, Columbaro M, et al
    Altered lipid metabolism could drive the bone marrow failure in fanconi anaemia.
    Br J Haematol. 2019;184:693-696.
    >> Share

  298. DARBARI DS, Liljencrantz J, Ikechi A, Martin S, et al
    Pain and opioid use after reversal of sickle cell disease following HLA-matched sibling haematopoietic stem cell transplant.
    Br J Haematol. 2019;184:690-693.
    >> Share

  299. MARKUS C, Saxon B, Metz M
    Ferritin as a functional biomarker of iron status in children and young adults.
    Br J Haematol. 2019;184:640-642.
    >> Share

  300. MALINOWSKI AK, Cheung P, Yang J, D'Souza R, et al
    Cord gas parameters in infants born to women with sickle cell disease: a retrospective matched cohort study.
    Br J Haematol. 2019;184:653-657.
    >> Share

  301. MAJUMDAR S, Tirona R, Mashegu H, Desai J, et al
    A phase 1 dose-finding study of intravenous L-citrulline in sickle cell disease: a potential novel therapy for sickle cell pain crisis.
    Br J Haematol. 2019;184:634-636.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016